
Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry conference that kicked off on Monday in San Francisco.
The medical device maker has been eyeing tuck-in deals as it seeks to diversify its portfolio, particularly in cardiology and neuroscience, with CEO Geoff Martha in November saying that they would prefer companies in "early stage or close to market."
The company's balance sheet gives it flexibility to execute a "meaningful number" of transactions without financial strain, Chief Financial Officer Thierry Piéton said at the J.P. Morgan healthcare conference on Monday.
"What's changing versus the last few years is coming back to doing more M&A," he said, adding that Medtronic's dividend policy remains unchanged.
Medtronic, which makes devices ranging from pacemakers to insulin pumps, reported a 3.7% rise in revenue to $33.6 billion in fiscal 2025.
The company is targeting deals in the low- to mid-single-digit billions of dollars, choosing targets that will supplement its internal R&D efforts, Martha said on Monday. The company has set up a new committee at the board level to move faster on deals, he added.
The executives said Medtronic is focused on two themes, expanding in areas where it already competes and acquiring enabling technologies for procedures such as cardiac ablation and surgical robotics.
The company has spent recent years improving operations by divesting non-core units and plans to spin off its diabetes business as MiniMed Group through a U.S. initial public offering following its struggles over the last few years.
It also added two new directors to its board last year after activist investor Elliott Investment Management emerged as one of its largest shareholders.
Medtronic now sees itself positioned to pursue strategic opportunities.
"We've earned the right to do these acquisition, and we've got the capacity, so we're going to step up," Piéton said.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona and Leroy Leo)
LATEST POSTS
- 1
What’s your chronotype? Knowing whether you’re a night owl or an early bird could help you do better on tests and avoid scams - 2
Exclusive-Head of Pemex's production arm to step down in coming days, sources say - 3
New York to require social media platforms to display mental health warnings - 4
Countdown to Artemis II: What to know about NASA's moon mission - 5
Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
Vote In favor of Your Favored Sort Of Bevarage
NASA's Voyager 1 set to achieve historic distance from Earth
Germany's first Omani LNG shipments arrive despite Middle East disruptions
The Manual for Electric Vehicles that will be hot merchants in 2023
The Most Moving TED Talks You Want to Watch
The most effective method to Pick the Best Wellbeing Highlights for Seniors in SUVs
How a toxic self-improvement trend with a funny name took over your feed
Vote In favor of Your Favored Language Interpretation Administration
Stolen Renoir, Cézanne and Matisse were probably uninsured, market sources say













